Juvelook Volume 200mg: Professional Reconstitution and Handling Guide

Juvelook Volume 200mg is specifically formulated as a body collagen biostimulator, designed for professional applications requiring significant volume restoration and collagen synthesis. It contains a unique blend of polylactic acid (PDLLA) and hyaluronic acid (HA), presented as a lyophilized powder. The product's intended use in professional settings necessitates strict adherence to reconstitution and handling protocols to maintain its chemical stability and ensure product integrity. This differentiates it from other biostimulators like Aesthefill Standard or traditional fillers. Professionals seeking to diversify their stock of collagen biostimulators may also consider sourcing products from our comprehensive Body collagen biostimulator catalog.

Juvelook Volume 200mg is manufactured by Pharma Research, a South Korean company known for its aesthetic innovations. Each unit typically contains 200mg of lyophilized powder. This powder requires specific reconstitution before clinical application. Understanding the product's origin and manufacturer is crucial for sourcing authentic supplies and ensuring compatibility with established clinic protocols. The wholesale price for a single unit is typically $237.0, with volume tier discounts available: 11 units at 4% off, 21 units at 5% off, 31 units at 6% off, and 51+ units at 8% off.

Accurate reconstitution is paramount for Juvelook Volume 200mg. This process converts the lyophilized powder into a ready-to-use suspension. While specific protocols may vary based on professional guidelines and manufacturer updates, the general steps involve:

• Preparation: Ensure a sterile field, including hands, instruments, and vials.
• Diluent Selection: Typically, sterile physiological saline (0.9% NaCl) is used as the diluent. The exact volume of diluent required is critical and should strictly follow manufacturer recommendations, usually ranging from 8-12ml for 200mg.
• Injection Technique: Slowly inject the chosen diluent into the Juvelook Volume vial. Direct, forceful injection can lead to foaming or uneven dispersion.
• Gentle Mixing: After diluent addition, the vial should be gently agitated, not shaken vigorously. Rolling the vial between the palms or gentle inversion over a period helps achieve uniform suspension. Avoid creating excessive bubbles.
• Resting Period: Allow the reconstituted solution to rest for a recommended period, often several hours (e.g., 30 minutes to 2 hours) or even overnight at room temperature, to ensure complete hydration of the PDLLA particles. This is a critical step for preventing nodule formation post-application.

For comparative insights into other preparation methods, professionals might review resources such as the Rejuran HB: A Professional Preparation and Handling Guide.

The final concentration of the reconstituted Juvelook Volume 200mg suspension directly influences its rheological properties and application characteristics. While specific dilution ratios and volumes are determined by the treating professional based on application area and desired outcome, general considerations include:

• Higher Concentration: May be appropriate for areas requiring more significant volumization.
• Lower Concentration: Can be utilized for broader dermal stimulation.

Professionals should always consult the official product documentation for precise dilution guidelines and consider the implications of different concentrations on product flow and distribution. When compared to related products like Juvelook 50mg, the 200mg variant is typically prepared for larger volume applications.

Proper storage is essential for maintaining the stability and integrity of Juvelook Volume 200mg, both before and after reconstitution.

Adherence to cold chain protocols during transit and storage in the clinic is vital for temperature-sensitive products. Once reconstituted, the product has a limited shelf life, typically up to 2 weeks when stored correctly. Always verify the manufacturer's specified post-reconstitution stability period on the product insert.

Upon receipt, clinic staff should inspect the packaging of Juvelook Volume 200mg for any signs of damage, tampering, or compromise. The integrity of the vial seal is crucial. Handle vials carefully to prevent breakage. All preparation should occur in a clean, aseptic environment to prevent contamination. Proper disposal of needles, syringes, and used vials must strictly follow clinic biohazard protocols. Maintain a clear inventory system to track lot numbers and expiration dates for all units in stock.